Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Deferred Taxes (2016 - 2020)

Cumberland Pharmaceuticals (CPIX) has disclosed Deferred Taxes for 9 consecutive years, with $21802.0 as the latest value for Q4 2020.

  • Quarterly Deferred Taxes changed 0.0% to $21802.0 in Q4 2020 from the year-ago period, while the trailing twelve-month figure was $21802.0 through Dec 2020, down 66.67% year-over-year, with the annual reading at $21802.0 for FY2020, 66.67% down from the prior year.
  • Deferred Taxes hit $21802.0 in Q4 2020 for Cumberland Pharmaceuticals, roughly flat from $21803.0 in the prior quarter.
  • In the past five years, Deferred Taxes ranged from a high of $3.5 million in Q2 2017 to a low of -$87210.0 in Q4 2017.
  • Historically, Deferred Taxes has averaged $454129.9 across 5 years, with a median of $81886.0 in 2018.
  • Biggest YoY gain for Deferred Taxes was 1294.48% in 2016; the steepest drop was 109.66% in 2016.
  • Year by year, Deferred Taxes stood at -$43109.0 in 2016, then crashed by 102.3% to -$87210.0 in 2017, then soared by 193.9% to $81886.0 in 2018, then plummeted by 73.37% to $21803.0 in 2019, then decreased by 0.0% to $21802.0 in 2020.
  • Business Quant data shows Deferred Taxes for CPIX at $21802.0 in Q4 2020, $21803.0 in Q4 2019, and $43605.0 in Q1 2019.